Competition

Competition Tests Novo Nordisk’s Grip on Weight-Loss Drug Market

Business Pen
[stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking...

Subscribe to Newsletter